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as carriers of O157 and O26 strains in Ireland (7,8). In 
Germany, cattle density has been shown to be significant-
ly associated with human VTEC O157 incidence but only 
marginally associated with O26 incidence (9); the same 
study showed no association between cattle density and 
VTEC O91 infection, indicating that not all serogroups 
necessarily share the same reservoirs. Alternatively, ani-
mals of the same species may be preferentially colonized 
with different serogroups at different times of the year or 
at different developmental ages. Other possible explana-
tions could be variation in survival characteristics be-
tween the 2 strains, which results in a different seasonal 
distribution in the environment, or specific human behav-
ior (e.g., seasonal food) resulting in more frequent expo-
sure to sources of VTEC O157 and VTEC O26 at different 
times of the year.
The consistent differences in seasonality identified 
here between the 2 most common VTEC serogroups sug-
gest the existence of noteworthy underlying differences in 
disease etiology between the strains. Further exploration is 
recommended.
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To the Editor: New Delhi metallo-β-lactamase 
(NDM)–producing Enterobacteriaceae have swiftly spread 
worldwide since an initial report in 2008 from a patient 
who had been transferred from India back home to Swe-
den (1). Epidemiologically, the global diffusion of NDM-1 
producers has been associated with the Indian subcontinent 
and the Balkan region, which are considered the primary 
and secondary reservoirs of these pathogens, respectively 
(1). However, recent reports suggest that countries in the 
Middle East may constitute another potential reservoir for 
NDM-1 producers (1). More than 100 NDM-producing 
isolates have been reported in the United States, most of 
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which were associated with recent travel from the Indian 
subcontinent (2,3). We report an NDM-1–producing Kleb-
siella pneumoniae strain that was recovered from a patient 
who had been transferred from Iran to a hospital in Florida, 
United States.
The patient was a 72-year-old woman with diabetes 
who had suffered a hip fracture while residing in Iran. 
After fixation of the bone failed, the patient underwent hip 
replacement, which was complicated by dislocation and 
an infected hematoma. She was transferred to a hospital 
in Florida in February 2014 for further care. The wound 
culture collected upon arrival grew K. pneumoniae K351. 
The patient underwent surgical debridement, implant re-
moval, and placement of an antimicrobial spacer for pros-
thetic joint infection. She was treated with tigecycline; 
however, the wound did not heal, and she underwent de-
bridement with removal of the spacer and placement of 
antimicrobial beads.
K. pneumoniae K351 from the patient was resistant 
to all β-lactams tested, including carbapenems, and highly 
resistant to aminoglycosides and fluoroquinolones, retain-
ing susceptibility only to tigecycline and colistin. PCR and 
sequencing revealed the presence of β-lactamase genes 
blaNDM-1, blaCTX-M-15, blaSHV-12, and blaTEM-1 and 16S rRNA 
methyltransferase genes rmtC and armA. The strain se-
quence type (ST) was ST147, which is one of the predomi-
nant NDM-producing K. pneumoniae lineages and has 
been reported in many countries (3,4). Conjugation experi-
ments using broth and filter mating methods did not yield 
any Escherichia coli J53 transconjugants with blaNDM-1, de-
spite repeated attempts. Plasmids of K351 were extracted 
by using the standard alkaline lysis method and used to 
transform E. coli TOP10-competent cells. An E. coli trans-
formant harboring plasmid pK351 grew on Mueller-Hinton 
agar plates supplemented with 200 µg/mL of ampicillin. 
The transformant exhibited resistance to all β-lactams, in-
cluding carbapenems and aminoglycosides; this resistance 
could be attributed to the presence of blaNDM-1 and rmtC in 
plasmid pK351, which was confirmed by PCR.
pK351 was fully sequenced on a PacBio RS II se-
quencing instrument (Pacific Biosciences, Menlo Park, 
CA) and annotated (GenBank accession no. KR351290) 
(5). pK351 is 106,844 bp in length, has an average GC 
content of 55.4%, and encodes IncFIB and IncFII-like 
replication proteins, with IncFIB belonging to B36 ac-
cording to the replicon sequencing typing scheme (6). 
pK351 is most closely related (98% coverage and 99% 
identity) to 3 blaNDM-1-carrying plasmids pKOX_NDM1, 
pRJF866, and pNDM-Ec1GN574 (GenBank accession 
nos. NC_021501, KF732966, and KJ812998, respective-
ly) (online Technical Appendix Figure, http://wwwnc.cdc.
gov/EID/article/22/4/15-1176-Techapp1.pdf). Compared 
with the 3 plasmids, pK351 is missing a 4,086-bp region 
between insertion sequence (IS) IS1 and IS903-like mo-
bile elements, probably due to IS1-mediated deletion. In 
addition, the region containing gene ccdBA between gene 
resD and an IS1 remnant is replaced by a region encod-
ing 2 hypothetical proteins in pK351. The remainder of 
pK351 exhibits 99.95% identity to the 3 related plasmids. 
The immediate genetic environment of blaNDM-1 in pK351 
is identical to that in the 3 related plasmids, encompassing 
blaNDM-1 itself and the downstream sequence, flanked by 
256-bp direct repeats (7).
Plasmids pKOX_NDM1 and pRJF866 were found in a 
K. oxytoca strain from Taiwan and a K. pneumoniae ST11 
strain from Shanghai, China, respectively (7,8). K. oxytoca 
(pKOX_NDM1) was isolated from a patient from Taiwan 
who underwent surgery in Jiangxi, China. K. pneumoniae 
ST11 (pRJF866) was isolated from a patient in a burn unit 
in Shanghai just after a highly related NDM-1–producing 
K. pneumoniae ST11 strain was isolated from another pa-
tient in the same unit who had traveled to Jiangxi Province 
(8). pNDM-Ec1GN574 was detected in an E. coli strain 
from a patient previously hospitalized in India before being 
admitted to a community hospital in Canada (9). Identifica-
tion of highly similar blaNDM-1–carrying plasmids in various 
strain lineages and species in different locales suggests ex-
tensive horizontal transfer of these plasmids among broad-
range hosts. Acquisition of these plasmids by globally dis-
tributed, multidrug-resistant K. pneumoniae lineages (ST11 
and ST147) is of grave concern.
The epidemiology of NDM-1–producing Enterobacte-
riaceae continues to evolve. The case reported here was 
imported to the United States upon patient transfer from 
Iran (10). The unusual path for this NDM-1–producing K. 
pneumoniae supports the hypothesis that the Middle East 
might be an additional reservoir for NDM producers.
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To the Editor: The current rates of animal and human 
brucellosis in southern Israel are unacceptably high (1). Un-
supervised livestock rearing, smuggling of herds, and the 
dissolution of Israel’s “test, slaughter, and compensate” pro-
gram for small ruminants in 1997 have generated a large, un-
controlled animal reservoir in the region. The Bedouin Arab 
inhabitants who live in close proximity to herds and con-
sume unpasteurized dairy products are disproportionately 
affected. Outbreaks from parts of Israel that were previously 
free of brucellosis are reported with increasing frequency. 
Moreover, 2 decades after supposed elimination of bovine 
brucellosis, a cattle herd adjacent to Bedouin grazing areas 
was found to be highly infected with Brucella melitensis (2).
We report 5 cases of severe brucellosis in patients 
from a community whose members typically do not raise 
herds and do not consume unpasteurized dairy products. 
The patients were Ethiopian-born Jews who exhibited fe-
ver and either respiratory signs or radiologic evidence of 
new pulmonary findings (Table). The true nature of the 
infection only became evident when B. melitensis was 
identified from blood cultures. Directed questioning re-
vealed that all patients participated in ceremonial slaugh-
ter of sheep that were purchased from Bedouin owners in 
southern Israel.
The diagnostic pitfalls encountered by the medical 
staff are exemplified in the case of patient 1 (Table). In May 
2014, this 68-year-old man was admitted to a hospital in 
southern Israel, with a 14-day history of fever, cough, and 
night sweats. His medical history was notable for asthma 
and previously treated pulmonary tuberculosis (TB). Com-
puted tomography scan of his chest showed a new 1.5-cm2 
apical lung lesion with irregular borders. Laboratory evalu-
ations were negative for rickettsiae, Coxiella burnetii, HIV, 
Plasmodium spp., and Mycobacterium tuberculosis. Four 
days after admission, gram-negative coccobacilli grew 
from his blood culture. Brucella IgM titer was 1:1,920. The 
patient received appropriate treatment for 6 weeks (Table) 
and recovered. Brucella IgM titers dropped to 1:40. Four 
months later, he returned to the infectious diseases clinic 
exhibiting fever, chills, and clinical and sonographic evi-
dence of epididymo-orchitis. Brucella IgM titers rose to 
1:1,240. Treatment was resumed for 3 months. In addition, 
a thoracoscopic biopsy of the lung lesion was performed 
to rule out malignancy. Pathologic examination of the bi-
opsy specimen revealed a focus of fibrosis, with giant cells 
surrounded by lymphocytes (online Technical Appendix 
Figure, http://wwwnc.cdc.gov/EID/article/22/4/15-1192-
Techapp1.pdf). After treatment, the patient’s symptoms re-
solved and titers returned to low levels.
The long symptom-to-diagnosis interval (range 21–
97 days) for patients in this report is alarming (Table). 
Treatment delays are associated with increased focal 
complications and relapse rates (3). Further, high case-
fatality rates, allegedly due to low physician awareness, 
were reported in a largely immigrant cohort of brucellosis 
patients in Germany (4). 
Several circumstances might have led to the failure to 
include brucellosis in the initial differential diagnosis for 
these patients, even in a disease-endemic region. First, we 
can assume that physicians are unfamiliar with the ceremo-
nial slaughter central to the celebrations of Ethiopian Jews. 
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